APOE and immunity: Research highlights
INTRODUCTION At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in...
Saved in:
Published in | Alzheimer's & dementia Vol. 19; no. 6; pp. 2677 - 2696 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.06.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 1552-5260 1552-5279 1552-5279 |
DOI | 10.1002/alz.13020 |
Cover
Abstract | INTRODUCTION
At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias.
METHODS
The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry.
RESULTS
During the 4‐day meeting, presenters illuminated aspects of the cross‐talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]).
DISCUSSION
This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development. |
---|---|
AbstractList | INTRODUCTION
At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias.
METHODS
The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry.
RESULTS
During the 4‐day meeting, presenters illuminated aspects of the cross‐talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]).
DISCUSSION
This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development. At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias.INTRODUCTIONAt the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias.The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry.METHODSThe meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry.During the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]).RESULTSDuring the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]).This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development.DISCUSSIONThis manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development. At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias. The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry. During the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]). This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development. INTRODUCTIONAt the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias. METHODSThe meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry. RESULTSDuring the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor alpha [TNF alpha]). DISCUSSIONThis manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development. INTRODUCTION: At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene ( APOE ) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias. METHODS: The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry. RESULTS: During the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]). DISCUSSION: This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development. |
Author | Petersen, Kellen K. TCW, Julia Lemere, Cynthia A. Weninger, Stacie C. Tansey, Malú Gámez Barnum, Christopher J. Batista, Andre F. Brickman, Adam M. Huggins, Lenique K. L. Tijms, Betty M. Sexton, Claire Jones, Nahdia S. Teunissen, Charlotte E. Koldamova, Radosveta Piña‐Escudero, Stefanie D. Dennison, Jessica Bu, Guojun Marcora, Edoardo Wallings, Rebecca Carrillo, Maria C. Marsh, Samuel E. Worley, Susan L Goate, Alison M. Reiman, Eric Wishard, Tyler James Hu, William T. Nielsen, Henrietta M. Haass, Christian Zetterberg, Henrik Qiu, Wei Qiao Wharton, Whitney Liddelow, Shane A. Petersen, Melissa Bradshaw, Elizabeth M. Gearon, Mary D. Wilcock, Donna M. Kloske, Courtney M. Quiroz, Yakeel T. Heneka, Michael T. Kant, Rik |
Author_xml | – sequence: 1 givenname: Courtney M. surname: Kloske fullname: Kloske, Courtney M. email: cmkloske@alz.org organization: Alzheimer's Association – sequence: 2 givenname: Christopher J. surname: Barnum fullname: Barnum, Christopher J. organization: INmune Bio, Inc – sequence: 3 givenname: Andre F. surname: Batista fullname: Batista, Andre F. organization: Harvard Medical School – sequence: 4 givenname: Elizabeth M. surname: Bradshaw fullname: Bradshaw, Elizabeth M. organization: Columbia University Irving Medical Center – sequence: 5 givenname: Adam M. surname: Brickman fullname: Brickman, Adam M. organization: Columbia University – sequence: 6 givenname: Guojun surname: Bu fullname: Bu, Guojun organization: Mayo Clinic – sequence: 7 givenname: Jessica surname: Dennison fullname: Dennison, Jessica organization: University of Miami Miller School of Medicine – sequence: 8 givenname: Mary D. surname: Gearon fullname: Gearon, Mary D. organization: University of Kentucky – sequence: 9 givenname: Alison M. surname: Goate fullname: Goate, Alison M. organization: Icahn School of Medicine at Mount Sinai – sequence: 10 givenname: Christian surname: Haass fullname: Haass, Christian organization: Germany 3 Munich Cluster for Systems Neurology (SyNergy) – sequence: 11 givenname: Michael T. surname: Heneka fullname: Heneka, Michael T. organization: Luxembourg Centre for Systems Biomedicine (LCSB) University of Luxembourg – sequence: 12 givenname: William T. surname: Hu fullname: Hu, William T. organization: Health Care Policy, and Aging Research – sequence: 13 givenname: Lenique K. L. surname: Huggins fullname: Huggins, Lenique K. L. organization: Yale School of Medicine – sequence: 14 givenname: Nahdia S. surname: Jones fullname: Jones, Nahdia S. organization: Georgetown University – sequence: 15 givenname: Radosveta surname: Koldamova fullname: Koldamova, Radosveta organization: School of Public Health University of Pittsburgh – sequence: 16 givenname: Cynthia A. surname: Lemere fullname: Lemere, Cynthia A. organization: Harvard Medical School – sequence: 17 givenname: Shane A. surname: Liddelow fullname: Liddelow, Shane A. organization: NYU Grossman School of Medicine – sequence: 18 givenname: Edoardo surname: Marcora fullname: Marcora, Edoardo organization: Icahn School of Medicine at Mount Sinai – sequence: 19 givenname: Samuel E. surname: Marsh fullname: Marsh, Samuel E. organization: Broad Institute of MIT and Harvard – sequence: 20 givenname: Henrietta M. surname: Nielsen fullname: Nielsen, Henrietta M. organization: Stockholm University – sequence: 21 givenname: Kellen K. surname: Petersen fullname: Petersen, Kellen K. organization: Albert Einstein College of Medicine – sequence: 22 givenname: Melissa surname: Petersen fullname: Petersen, Melissa organization: University of North Texas Health Science Center – sequence: 23 givenname: Stefanie D. surname: Piña‐Escudero fullname: Piña‐Escudero, Stefanie D. organization: University of California – sequence: 24 givenname: Wei Qiao surname: Qiu fullname: Qiu, Wei Qiao organization: Boston University School of Medicine – sequence: 25 givenname: Yakeel T. surname: Quiroz fullname: Quiroz, Yakeel T. organization: Harvard Medical School – sequence: 26 givenname: Eric surname: Reiman fullname: Reiman, Eric organization: Banner Research – sequence: 27 givenname: Claire orcidid: 0000-0002-3846-2986 surname: Sexton fullname: Sexton, Claire organization: Alzheimer's Association – sequence: 28 givenname: Malú Gámez surname: Tansey fullname: Tansey, Malú Gámez organization: University of Florida – sequence: 29 givenname: Julia surname: TCW fullname: TCW, Julia organization: Boston University School of Medicine – sequence: 30 givenname: Charlotte E. surname: Teunissen fullname: Teunissen, Charlotte E. organization: Vrije Universiteit Amsterdam – sequence: 31 givenname: Betty M. surname: Tijms fullname: Tijms, Betty M. organization: Neurodegeneration – sequence: 32 givenname: Rik surname: Kant fullname: Kant, Rik organization: Amsterdam University Medical Center – sequence: 33 givenname: Rebecca surname: Wallings fullname: Wallings, Rebecca organization: University of Florida – sequence: 34 givenname: Stacie C. surname: Weninger fullname: Weninger, Stacie C. organization: FBRI – sequence: 35 givenname: Whitney surname: Wharton fullname: Wharton, Whitney organization: EmoryUniversity – sequence: 36 givenname: Donna M. surname: Wilcock fullname: Wilcock, Donna M. organization: University of Kentucky – sequence: 37 givenname: Tyler James surname: Wishard fullname: Wishard, Tyler James organization: Los Angeles – sequence: 38 givenname: Susan L surname: Worley fullname: Worley, Susan L organization: Independent science writer – sequence: 39 givenname: Henrik surname: Zetterberg fullname: Zetterberg, Henrik organization: Clear Water Bay – sequence: 40 givenname: Maria C. surname: Carrillo fullname: Carrillo, Maria C. organization: Alzheimer's Association |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36975090$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-219590$$DView record from Swedish Publication Index https://gup.ub.gu.se/publication/327516$$DView record from Swedish Publication Index |
BookMark | eNp90U1LwzAcBvAgE-emB7-A9CQKdstL0zbeypwvMJiIevASsjTtIn0zaRnz09vZuYMwDyEh_P5PIM8A9IqyUACcIThCEOKxyL5GiEAMD8AxohS7FAestzv7sA8G1n5A6MEQ0SPQJz4LKGTwGFxET_OpI4rY0XneFLpe3zjPyiph5NJZ6nSZtau2J-AwEZlVp9t9CF7vpi-TB3c2v3-cRDNXeoRClyYEe2H7TEwFDhTGKCEkECxkJGYqpoQxlZAgprGMqQwFxAKJgBEBF8IPZEiGwO1y7UpVzYJXRufCrHkpNE-birdXacOt4gQHFPmtv97rb_VbxEuTcttwjBhlsOWXHa9M-dkoW_NcW6myTBSqbCzHIaaIeqG_ST7f0maRq3iX_Pt1LbjqgDSltUYlO4Ig39TC21r4Ty2tHf-xUtei1mVRG6Gz_yZWOlPr_dE8mr13E9-UAJt- |
CitedBy_id | crossref_primary_10_1002_2211_5463_13704 crossref_primary_10_1002_alz_14291 crossref_primary_10_1016_j_imbio_2025_152895 crossref_primary_10_1111_pcn_13704 crossref_primary_10_1159_000541542 crossref_primary_10_3390_ijms241310440 crossref_primary_10_1002_wnan_1946 crossref_primary_10_3390_ijms251910432 crossref_primary_10_1016_j_arr_2024_102471 crossref_primary_10_3390_ijms241713395 |
Cites_doi | 10.1038/s41591‐019‐0695‐9 10.1186/s13024‐015‐0048‐1 10.1073/pnas.0900345106 10.1212/NXG.0000000000000571 10.3233/JAD‐160163 10.1038/s41593‐021‐00905‐6 10.1038/s41591‐019‐0611‐3 10.1186/s13195‐019‐0546‐4 10.1126/science.aal3222 10.1194/jlr.R800069‐JLR200 10.2217/17460875.3.5.505 10.1371/journal.pone.0219668 10.1016/j.nbd.2022.105630 10.1007/s00109‐016‐1427‐y 10.1038/s41593‐020‐0602‐1 10.1016/j.biopsych.2017.05.014 10.1016/j.exger.2014.02.004 10.3390/nu7095341 10.1073/pnas.1525466113 10.1038/s41577‐018‐0051‐1 10.3389/fimmu.2020.00754 10.15252/emmm.201911227 10.1016/j.neuron.2017.04.043 10.1038/nn.3599 10.1177/0891988705281868 10.1038/s41593‐022‐01022‐8 10.1016/j.neurobiolaging.2012.09.012 10.1016/j.neuron.2017.09.003 10.1002/alz.051948 10.1016/j.jalz.2016.07.004 10.1016/j.neuron.2020.09.029 10.1038/s41467‐021‐22479‐4 10.1038/s41467‐021‐23762‐0 10.1186/s13195‐016‐0231‐9 10.1038/s41593‐018‐0296‐9 10.1016/j.neuron.2011.07.022 10.1038/s41586‐019‐0924‐x 10.1001/jamaneurol.2018.0821 10.1523/JNEUROSCI.3266‐12.2012 10.1523/JNEUROSCI.1871‐19.2019 10.1093/brain/awy188 10.1038/s41593‐019‐0560‐7 10.1126/science.abf9277 10.1016/0197‐4580(95)00021‐6 10.1038/s41467‐021‐24220‐7 10.1038/s41586‐019‐1195‐2 10.1016/j.neuron.2019.12.007 10.1016/S1474‐4422(15)70016‐5 10.1016/j.chom.2009.06.007 10.1016/j.brainresrev.2006.11.002 10.1186/s13024‐020‐00394‐4 10.1016/j.bbi.2021.12.008 10.1186/s12974‐020‐01915‐0 10.1016/j.cell.2017.05.018 10.1186/s40478‐021‐01263‐x 10.3892/etm.2021.9778 10.3389/fneur.2018.00625 10.1126/science.aay0793 10.1111/jgs.13627 10.1371/journal.pmed.1002270 10.2147/CLEP.S37929 10.3233/JAD‐150778 10.1001/jamapsychiatry.2014.1060 10.2174/1567205013666160930110551 10.1016/j.neuron.2020.10.008 10.1002/gps.4871 10.1523/JNEUROSCI.2262‐17.2018 10.1126/science.8346443 10.1016/j.neuron.2017.03.042 10.1017/s0317167100013949 10.1007/s00401‐020‐02193‐z 10.1038/s41467‐019‐14279‐8 10.1097/WAD.0000000000000462 10.1001/jamaneurol.2015.1721 10.1038/s41586‐021‐03960‐y 10.1124/pr.112.005850 10.1212/WNL.0000000000010629 10.1007/s12035‐014‐8657‐1 10.1126/science.abf7844 10.1016/j.neuron.2020.05.014 10.1016/j.jalz.2018.02.018 10.3233/JAD‐170767 10.1016/S1474‐4422(16)00067‐3 10.1084/jem.20200785 10.1016/j.immuni.2018.11.004 10.1212/wnl.43.8.1467 10.1038/s41582‐018‐0032‐9 10.3390/genes10030222 10.1186/s13195‐022‐01058‐9 10.1073/pnas.1525528113 10.3389/fimmu.2018.00586 10.1016/j.jns.2013.05.028 10.1038/s41593‐020‐0650‐6 10.1001/jama.2015.4668 10.3233/ADR‐200203 10.3389/fncel.2019.00063 10.1016/j.neurobiolaging.2012.03.002 10.3233/JAD‐210065 10.1016/j.nbd.2020.104755 10.1212/WNL.0000000000012512 10.1007/s00401‐014‐1375‐y 10.1186/s13195‐020‐00628‐z 10.1038/nn.4338 10.1371/journal.pmed.1002254 10.1016/j.neuron.2022.03.008 10.1038/nature21029 10.1002/alz.12205 10.1016/j.jalz.2015.12.007 10.1038/s41593‐022‐01061‐1 10.1002/iub.1314 10.1038/ncomms7176 10.15252/embj.201899430 10.1186/s13195‐017‐0313‐3 10.1093/brain/awaa325 10.1212/wnl.56.1.49 10.2147/jir.s4397 10.1016/j.nicl.2013.12.012 10.1073/pnas.90.5.1977 10.1093/jnen/nlab085 10.1016/j.jalz.2019.03.007 |
ContentType | Journal Article |
Copyright | 2023 The Authors. published by Wiley Periodicals LLC on behalf of Alzheimer's Association. 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association. |
Copyright_xml | – notice: 2023 The Authors. published by Wiley Periodicals LLC on behalf of Alzheimer's Association. – notice: 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ABAVF ADTPV AOWAS D8T DG7 ZZAVC F1U |
DOI | 10.1002/alz.13020 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic SWEPUB Stockholms universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Stockholms universitet SwePub Articles full text SWEPUB Göteborgs universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1552-5279 |
EndPage | 2696 |
ExternalDocumentID | oai_gup_ub_gu_se_327516 oai_DiVA_org_su_219590 36975090 10_1002_alz_13020 ALZ13020 |
Genre | reviewArticle Research Support, U.S. Gov't, Non-P.H.S Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: R01 AG054005 – fundername: NIA NIH HHS grantid: T32 AG000222 – fundername: NIA NIH HHS grantid: R01 AG077636 – fundername: NIA NIH HHS grantid: R01 AG076018 – fundername: NIAAA NIH HHS grantid: R01 AA016829 – fundername: NIA NIH HHS grantid: P30 AG059304 – fundername: NIA NIH HHS grantid: R01 AG067581 – fundername: NINDS NIH HHS grantid: UF1 NS125488 – fundername: NIA NIH HHS grantid: P01 AG078116 – fundername: NIA NIH HHS grantid: R01 AG066198 |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1OC 1~. 1~5 24P 33P 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 8FI 8FJ 8P~ AACTN AAEDT AAHHS AAIKJ AAKOC AALRI AANLZ AAOAW AAXLA AAXUO AAYCA ABBQC ABCQJ ABCUV ABIVO ABJNI ABMAC ABMZM ABUWG ABWVN ACCFJ ACCMX ACCZN ACGFS ACGOF ACPOU ACRPL ACXQS ADBBV ADBTR ADEZE ADHUB ADKYN ADMUD ADNMO ADPDF ADVLN ADZMN ADZOD AEEZP AEIGN AEKER AENEX AEQDE AEUYR AEVXI AFKRA AFTJW AFWVQ AGHFR AGUBO AGWIK AGYEJ AITUG AIURR AIWBW AJBDE AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQN AMFUW AMRAJ AMYDB ANZVX AZQEC BENPR BFHJK BLXMC C45 CCPQU DCZOG EBS EJD EMOBN EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYUFA G-Q GBLVA HMCUK HVGLF HX~ HZ~ IHE J1W K9- LATKE LEEKS M0R M41 MO0 MOBAO N9A NAPCQ O-L O9- OAUVE OVD OVEED OZT P-8 P-9 P2P PC. PGMZT PIMPY PSYQQ Q38 QTD RIG ROL RPM RPZ SDF SDG SEL SES SSZ SUPJJ T5K TEORI UKHRP ~G- AAYWO AAYXX ACVFH ADCNI AEUPX AFPUW AGHNM AIGII AKBMS AKYEP CITATION PHGZM PHGZT AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EFLBG EIF NPM PJZUB PPXIY PUEGO ~HD 7X8 ABAVF ADTPV AOWAS D8T DG7 ZZAVC F1U |
ID | FETCH-LOGICAL-c4350-5f3248040d5a27e221f337a9893d9ed5399ef37d5dcd5c8a02a1a793a0ba67c83 |
IEDL.DBID | 24P |
ISSN | 1552-5260 1552-5279 |
IngestDate | Wed Sep 10 03:17:37 EDT 2025 Wed Sep 10 00:31:03 EDT 2025 Fri Jul 11 03:47:04 EDT 2025 Wed Sep 24 03:02:35 EDT 2025 Tue Jul 01 01:52:15 EDT 2025 Thu Apr 24 22:54:43 EDT 2025 Wed Jan 22 16:20:29 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | biomarkers neurodegeneration tau TREM2 amyloid beta neuroglia inflammation neuroinflammation dementia APOE astrocytes Alzheimer's disease microglia |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4350-5f3248040d5a27e221f337a9893d9ed5399ef37d5dcd5c8a02a1a793a0ba67c83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-3846-2986 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Falz.13020 |
PMID | 36975090 |
PQID | 2825154866 |
PQPubID | 23479 |
PageCount | 20 |
ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_327516 swepub_primary_oai_DiVA_org_su_219590 proquest_miscellaneous_2825154866 pubmed_primary_36975090 crossref_primary_10_1002_alz_13020 crossref_citationtrail_10_1002_alz_13020 wiley_primary_10_1002_alz_13020_ALZ13020 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | June 2023 |
PublicationDateYYYYMMDD | 2023-06-01 |
PublicationDate_xml | – month: 06 year: 2023 text: June 2023 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Alzheimer's & dementia |
PublicationTitleAlternate | Alzheimers Dement |
PublicationYear | 2023 |
References | 2019; 10 2015; 72 2019; 13 2019; 12 2019; 15 2019; 14 2019; 566 2020; 17 2022; 25 2020; 15 2020; 12 2020; 11 2018; 9 2022; 165 2019; 22 2020; 95 2011; 71 2019; 25 2020; 217 2014; 17 2001; 56 2018; 33 2017; 169 2018; 38 2021; 81 2021; 80 2022; 110 2016; 19 2020; 140 2020; 40 2020; 143 1993; 43 2019; 38 2016; 94 2012; 39 2015; 129 2016; 15 2012; 32 2016; 12 2022; 100 2018; 18 2015; 63 2020; 26 2022; 14 2013; 333 2021; 373 2020; 23 2017; 541 2019; 570 2005; 18 2018; 14 2009; 106 2021; 24 2021; 21 2019; 50 2019; 366 2018; 83 2008; 3 2008; 1 2017; 356 2017; 9 2014; 66 2021; 35 2020; 4 2014; 4 2009; 50 2021; 599 2020; 137 2016; 113 2014; 50 2018; 75 2014; 6 2012; 64 2014; 53 2021; 9 2021; 109 2018; 141 2021; 7 2015; 14 2015; 6 1995; 16 2015; 10 2016; 53 2020; 105 1993; 261 2020; 107 2016; 50 1993; 90 2018; 62 2007; 53 2015; 7 2020; 108 2017; 94 2017; 96 2021; 12 2017; 14 2015; 313 2021 2013; 34 2021; 17 2017; 13 2009; 6 2014; 71 e_1_2_12_6_1 e_1_2_12_2_1 e_1_2_12_17_1 e_1_2_12_111_1 e_1_2_12_115_1 e_1_2_12_108_1 e_1_2_12_20_1 e_1_2_12_66_1 e_1_2_12_43_1 e_1_2_12_85_1 e_1_2_12_24_1 e_1_2_12_47_1 e_1_2_12_89_1 e_1_2_12_62_1 e_1_2_12_81_1 e_1_2_12_100_1 e_1_2_12_123_1 e_1_2_12_28_1 e_1_2_12_104_1 e_1_2_12_31_1 e_1_2_12_77_1 e_1_2_12_54_1 e_1_2_12_96_1 e_1_2_12_35_1 e_1_2_12_58_1 e_1_2_12_12_1 e_1_2_12_73_1 e_1_2_12_50_1 e_1_2_12_92_1 e_1_2_12_3_1 e_1_2_12_18_1 e_1_2_12_110_1 e_1_2_12_114_1 e_1_2_12_21_1 e_1_2_12_44_1 e_1_2_12_63_1 e_1_2_12_86_1 e_1_2_12_107_1 e_1_2_12_25_1 e_1_2_12_48_1 e_1_2_12_67_1 e_1_2_12_40_1 e_1_2_12_82_1 e_1_2_12_122_1 e_1_2_12_29_1 e_1_2_12_103_1 e_1_2_12_119_1 e_1_2_12_32_1 e_1_2_12_55_1 e_1_2_12_74_1 e_1_2_12_97_1 e_1_2_12_36_1 e_1_2_12_59_1 e_1_2_12_78_1 e_1_2_12_13_1 e_1_2_12_7_1 e_1_2_12_51_1 e_1_2_12_70_1 e_1_2_12_93_1 e_1_2_12_4_1 e_1_2_12_19_1 e_1_2_12_38_1 e_1_2_12_113_1 e_1_2_12_41_1 e_1_2_12_87_1 e_1_2_12_106_1 e_1_2_12_22_1 e_1_2_12_64_1 e_1_2_12_45_1 e_1_2_12_26_1 e_1_2_12_68_1 e_1_2_12_83_1 e_1_2_12_60_1 e_1_2_12_49_1 e_1_2_12_121_1 e_1_2_12_102_1 e_1_2_12_52_1 e_1_2_12_98_1 e_1_2_12_118_1 e_1_2_12_33_1 e_1_2_12_75_1 e_1_2_12_56_1 e_1_2_12_37_1 e_1_2_12_79_1 e_1_2_12_14_1 e_1_2_12_90_1 e_1_2_12_8_1 e_1_2_12_10_1 e_1_2_12_94_1 e_1_2_12_71_1 e_1_2_12_5_1 e_1_2_12_16_1 e_1_2_12_112_1 e_1_2_12_39_1 e_1_2_12_116_1 e_1_2_12_42_1 e_1_2_12_65_1 e_1_2_12_88_1 e_1_2_12_109_1 e_1_2_12_23_1 e_1_2_12_46_1 e_1_2_12_69_1 e_1_2_12_80_1 e_1_2_12_61_1 e_1_2_12_84_1 e_1_2_12_27_1 e_1_2_12_101_1 e_1_2_12_120_1 e_1_2_12_105_1 e_1_2_12_30_1 e_1_2_12_53_1 e_1_2_12_76_1 e_1_2_12_99_1 e_1_2_12_117_1 e_1_2_12_34_1 e_1_2_12_57_1 e_1_2_12_15_1 e_1_2_12_91_1 e_1_2_12_11_1 e_1_2_12_72_1 e_1_2_12_95_1 e_1_2_12_9_1 |
References_xml | – volume: 90 start-page: 1977 year: 1993 end-page: 1981 article-title: Apolipoprotein E: high‐avidity binding to beta‐amyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer disease publication-title: Proc Natl Acad Sci USA – volume: 143 start-page: 3776 year: 2020 end-page: 3792 article-title: Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics publication-title: Brain J Neurol – volume: 23 start-page: 167 year: 2020 end-page: 171 article-title: Microglial microRNAs mediate sex‐specific responses to tau pathology publication-title: Nat Neurosci – volume: 18 start-page: 759 year: 2018 end-page: 772 article-title: Interplay between innate immunity and Alzheimer disease: aPOE and TREM2 in the spotlight publication-title: Nat Rev Immunol – volume: 19 start-page: 987 year: 2016 end-page: 991 article-title: A polarizing question: do M1 and M2 microglia exist? publication-title: Nat Neurosci – volume: 599 start-page: 102 year: 2021 end-page: 107 article-title: Neurotoxic reactive astrocytes induce cell death via saturated lipids publication-title: Nature – volume: 570 start-page: 332 year: 2019 end-page: 337 article-title: Single‐cell transcriptomic analysis of Alzheimer's disease publication-title: Nature – volume: 15 start-page: 451 year: 2016 end-page: 452 article-title: Sex differences in Alzheimer's disease and other dementias publication-title: Lancet Neurol – volume: 14 start-page: 457 year: 2018 end-page: 469 article-title: Sex differences in Alzheimer disease ‐ the gateway to precision medicine publication-title: Nat Rev Neurol – volume: 50 start-page: 534 year: 2014 end-page: 544 article-title: Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview publication-title: Mol Neurobiol – volume: 50 start-page: S183 year: 2009 end-page: S188 article-title: Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS publication-title: J Lipid Res – volume: 81 start-page: 339 year: 2021 end-page: 354 article-title: Plasma apolipoprotein E3 and glucose levels are associated in APOE ɛ3/ɛ4 carriers publication-title: J Alzheimers Dis JAD – volume: 165 year: 2022 article-title: Soluble TREM2: innocent bystander or active player in neurological diseases? publication-title: Neurobiol Dis – volume: 12 start-page: 216 year: 2016 end-page: 224 article-title: Inequalities in dementia incidence between six racial and ethnic groups over 14 years publication-title: Alzheimers Dement J Alzheimers Assoc – volume: 50 start-page: 71 year: 2016 end-page: 76 article-title: A meta‐analysis of Alzheimer's disease incidence and prevalence comparing African‐Americans and Caucasians publication-title: J Alzheimers Dis JAD – volume: 6 start-page: 10 year: 2009 end-page: 21 article-title: Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system publication-title: Cell Host Microbe – volume: 72 start-page: 1124 year: 2015 end-page: 1131 article-title: Characterizing apolipoprotein E ε4 carriers and noncarriers with the clinical diagnosis of mild to moderate Alzheimer dementia and minimal β‐amyloid peptide plaques publication-title: JAMA Neurol – volume: 39 start-page: 436 year: 2012 end-page: 445 article-title: Early‐onset familial Alzheimer's disease (EOFAD) publication-title: Can J Neurol Sci J Can Sci Neurol – volume: 100 start-page: 243 year: 2022 end-page: 253 article-title: Associations of circulating C‐reactive proteins, APOE ε4, and brain markers for Alzheimer's disease in healthy samples across the lifespan publication-title: Brain Behav Immun – volume: 34 start-page: 1051 year: 2013 end-page: 1059 article-title: Neuroinflammatory phenotype in early Alzheimer's disease publication-title: Neurobiol Aging – volume: 62 start-page: 833 year: 2018 end-page: 840 article-title: Longitudinal changes in serum glucose levels are associated with metabolic changes in Alzheimer's disease related brain regions publication-title: J Alzheimers Dis JAD – volume: 12 start-page: 65 year: 2020 article-title: APOE ε4 genotype‐dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease publication-title: Alzheimers Res Ther – volume: 129 start-page: 167 year: 2015 end-page: 182 article-title: Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease publication-title: Acta Neuropathol (Berl) – volume: 16 start-page: 271 year: 1995 end-page: 278 article-title: Staging of Alzheimer's disease‐related neurofibrillary changes publication-title: Neurobiol Aging – volume: 9 start-page: 586 year: 2018 article-title: Age and age‐related diseases: role of inflammation triggers and cytokines publication-title: Front Immunol – volume: 94 start-page: 759 year: 2017 end-page: 773 article-title: Diverse requirements for microglial survival, specification, and function revealed by defined‐medium cultures publication-title: Neuron – volume: 23 start-page: 927 year: 2020 end-page: 938 article-title: Alzheimer's‐associated PLCγ2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia publication-title: Nat Neurosci – volume: 53 start-page: 344 year: 2007 end-page: 354 article-title: The origin and cell lineage of microglia: new concepts publication-title: Brain Res Rev – volume: 14 year: 2019 article-title: The impact of APOE genotype on survival: results of 38,537 participants from six population‐based cohorts (E2‐CHARGE) publication-title: PLoS ONE – volume: 94 start-page: 739 year: 2016 end-page: 746 article-title: Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders publication-title: J Mol Med Berl Ger – volume: 4 start-page: 281 year: 2020 end-page: 286 article-title: Influence of APOE genotype on mortality and cognitive impairment publication-title: J Alzheimers Dis Rep – volume: 11 start-page: 754 year: 2020 article-title: The important interface between apolipoprotein E and neuroinflammation in Alzheimer's disease publication-title: Front Immunol – volume: 217 year: 2020 article-title: Anti‐human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model publication-title: J Exp Med – volume: 373 year: 2021 article-title: Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders publication-title: Science – volume: 313 start-page: 1924 year: 2015 end-page: 1938 article-title: Prevalence of cerebral amyloid pathology in persons without dementia: a meta‐analysis publication-title: JAMA – volume: 13 start-page: 63 year: 2019 article-title: Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration publication-title: Front Cell Neurosci – volume: 373 year: 2021 article-title: Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma publication-title: Science – volume: 35 start-page: 306 year: 2021 end-page: 314 article-title: A comparison of methods for predicting future cognitive status: mixture modeling, latent class analysis, and competitors publication-title: Alzheimer Dis Assoc Disord – volume: 113 start-page: E1316 year: 2016 end-page: E1325 article-title: The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function publication-title: Proc Natl Acad Sci U S A – volume: 25 start-page: 306 year: 2022 end-page: 316 article-title: Dissection of artifactual and confounding glial signatures by single‐cell sequencing of mouse and human brain publication-title: Nat Neurosci – volume: 113 start-page: E1738 year: 2016 end-page: E1746 article-title: New tools for studying microglia in the mouse and human CNS publication-title: Proc Natl Acad Sci USA – volume: 12 start-page: 2185 year: 2021 article-title: Therapeutic B‐cell depletion reverses progression of Alzheimer's disease publication-title: Nat Commun – volume: 12 year: 2020 article-title: Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region publication-title: EMBO Mol Med – volume: 40 start-page: 1956 year: 2020 end-page: 1974 article-title: Trem2 deletion reduces late‐stage amyloid plaque accumulation, elevates the Aβ42:aβ40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer's Mouse Model publication-title: J Neurosci Off J Soc Neurosci – volume: 3 start-page: 505 year: 2008 end-page: 530 article-title: Apolipoprotein E and cholesterol in aging and disease in the brain publication-title: Future Lipidol – volume: 137 year: 2020 article-title: ApoE and cerebral insulin: trafficking, receptors, and resistance publication-title: Neurobiol Dis – volume: 94 start-page: 278 year: 2017 end-page: 293 article-title: iPSC‐derived human microglia‐like cells to study neurological diseases publication-title: Neuron – volume: 22 start-page: 191 year: 2019 end-page: 204 article-title: Loss of TREM2 function increases amyloid seeding but reduces plaque‐associated ApoE publication-title: Nat Neurosci – year: 2021 article-title: Impact of C‐reactive protein on cognition and Alzheimer disease biomarkers in homozygous apolipoprotein E ɛ4 carriers publication-title: Neurology – volume: 7 year: 2021 article-title: African Americans have differences in CSF soluble TREM2 and associated genetic variants publication-title: Neurol Genet – volume: 7 start-page: 7332 year: 2015 end-page: 7357 article-title: Shared neuropathological characteristics of obesity, Type 2 diabetes and Alzheimer's disease: impacts on cognitive decline publication-title: Nutrients – volume: 25 start-page: 1680 year: 2019 end-page: 1983 article-title: Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report publication-title: Nat Med – volume: 80 start-page: 922 year: 2021 end-page: 932 article-title: Inflammatory pathways are impaired in Alzheimer disease and differentially associated With apolipoprotein E status publication-title: J Neuropathol Exp Neurol – volume: 71 start-page: 799 year: 2011 end-page: 811 article-title: Development of a method for the purification and culture of rodent astrocytes publication-title: Neuron – volume: 261 start-page: 921 year: 1993 end-page: 923 article-title: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families publication-title: Science – volume: 108 start-page: 801 year: 2020 end-page: 821 article-title: Emerging microglia biology defines novel therapeutic approaches for Alzheimer's disease publication-title: Neuron – volume: 169 start-page: 1276 year: 2017 end-page: 1290 article-title: A unique microglia type associated with restricting development of Alzheimer's disease publication-title: Cell – volume: 75 start-page: 989 year: 2018 end-page: 998 article-title: Sex‐specific association of apolipoprotein E with cerebrospinal fluid levels of Tau publication-title: JAMA Neurol – volume: 6 start-page: 37 year: 2014 end-page: 48 article-title: Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences publication-title: Clin Epidemiol – volume: 105 start-page: 837 year: 2020 end-page: 854 article-title: TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge publication-title: Neuron – volume: 83 start-page: 300 year: 2018 end-page: 310 article-title: Untangling genetic risk for Alzheimer's disease publication-title: Biol Psychiatry – volume: 18 start-page: 213 year: 2005 end-page: 217 article-title: Cognitive decline and literacy among ethnically diverse elders publication-title: J Geriatr Psychiatry Neurol – volume: 64 start-page: 1004 year: 2012 end-page: 1026 article-title: Tumor necrosis factor‐induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales publication-title: Pharmacol Rev – volume: 21 start-page: 347 year: 2021 article-title: The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer's disease: a systematic review and meta‐analysis publication-title: Exp Ther Med – volume: 56 start-page: 49 year: 2001 end-page: 56 article-title: Incidence of AD in African‐Americans, Caribbean Hispanics, and Caucasians in northern Manhattan publication-title: Neurology – volume: 11 start-page: 667 year: 2020 article-title: Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000‐person neuropathological study publication-title: Nat Commun – volume: 1 start-page: 29 year: 2008 end-page: 39 article-title: Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease publication-title: J Inflamm Res – volume: 107 start-page: 436 year: 2020 end-page: 453 article-title: CD49f is a novel marker of functional and reactive human iPSC‐derived astrocytes publication-title: Neuron – volume: 33 start-page: 688 year: 2018 end-page: 694 article-title: TNF alpha inhibitors in Alzheimer's disease: a systematic review publication-title: Int J Geriatr Psychiatry – volume: 6 start-page: 6176 year: 2015 article-title: Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques publication-title: Nat Commun – volume: 106 start-page: 6820 year: 2009 end-page: 6825 article-title: Fibrillar amyloid‐beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease publication-title: Proc Natl Acad Sci U S A – volume: 140 start-page: 513 year: 2020 end-page: 534 article-title: TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis publication-title: Acta Neuropathol (Berl) – volume: 17 start-page: 238 year: 2020 article-title: Therapeutic Trem2 activation ameliorates amyloid‐beta deposition and improves cognition in the 5XFAD model of amyloid deposition publication-title: J Neuroinflammation – volume: 356 year: 2017 article-title: An environment‐dependent transcriptional network specifies human microglia identity publication-title: Science – volume: 25 start-page: 588 year: 2022 end-page: 595 article-title: Single‐cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease publication-title: Nat Neurosci – volume: 14 year: 2017 article-title: APP, PSEN1, and PSEN2 mutations in early‐onset Alzheimer disease: a genetic screening study of familial and sporadic cases publication-title: PLoS Med – volume: 38 year: 2019 article-title: Beclin1‐driven autophagy modulates the inflammatory response of microglia via NLRP3 publication-title: EMBO J – volume: 10 start-page: 52 year: 2015 article-title: Genetics ignite focus on microglial inflammation in Alzheimer's disease publication-title: Mol Neurodegener – volume: 15 start-page: 41 year: 2020 article-title: Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice publication-title: Mol Neurodegener – volume: 9 start-page: 5 year: 2017 article-title: Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism publication-title: Alzheimers Res Ther – volume: 15 start-page: 776 year: 2019 end-page: 787 article-title: Inflammatory biomarkers in Alzheimer's disease plasma publication-title: Alzheimers Dement J Alzheimers Assoc – volume: 4 start-page: 461 year: 2014 end-page: 472 article-title: ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease publication-title: NeuroImage Clin – volume: 108 start-page: 801 year: 2020 end-page: 821 article-title: Emerging microglia biology defines novel therapeutic approaches for Alzheimer's disease ‐ ScienceDirect 2020 publication-title: Neuron – volume: 63 start-page: 1749 year: 2015 end-page: 1756 article-title: Modulation of renin‐angiotensin system may slow conversion from mild cognitive umpairment to Alzheimer's disease publication-title: J Am Geriatr Soc – volume: 366 start-page: 1134 year: 2019 end-page: 1139 article-title: Brain cell type‐specific enhancer‐promoter interactome maps and disease‐risk association publication-title: Science – volume: 12 start-page: 3416 year: 2021 article-title: Phospholipids of APOE lipoproteins activate microglia in an isoform‐specific manner in preclinical models of Alzheimer's disease publication-title: Nat Commun – volume: 17 start-page: 131 year: 2014 end-page: 143 article-title: Identification of a unique TGF‐β‐dependent molecular and functional signature in microglia publication-title: Nat Neurosci – volume: 12 start-page: 4001 year: 2021 article-title: Higher CSF sTNFR1‐related proteins associate with better prognosis in very early Alzheimer's disease publication-title: Nat Commun – volume: 95 start-page: e2378 year: 2020 end-page: e2388 article-title: Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype publication-title: Neurology – volume: 14 start-page: 535 year: 2018 end-page: 562 article-title: NIA‐AA Research Framework: toward a biological definition of Alzheimer's disease publication-title: Alzheimers Dement J Alzheimers Assoc – volume: 333 start-page: 9 year: 2013 end-page: 12 article-title: Association of plasma C‐reactive protein levels with the diagnosis of Alzheimer's disease publication-title: J Neurol Sci – volume: 17 start-page: 466 year: 2021 end-page: 474 article-title: APOE alleles’ association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos‐investigation of neurocognitive aging (HCHS/SOL) publication-title: Alzheimers Dement – volume: 96 start-page: 115 year: 2017 end-page: 129 article-title: Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes publication-title: Neuron – volume: 141 start-page: 2740 year: 2018 end-page: 2754 article-title: Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease publication-title: Brain – volume: 50 start-page: 253 year: 2019 end-page: 271 article-title: Single‐cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell‐state changes publication-title: Immunity – volume: 9 start-page: 625 year: 2018 article-title: In vivo imaging of glial activation in Alzheimer's disease publication-title: Front Neurol – volume: 566 start-page: 388 year: 2019 end-page: 392 article-title: Spatial and temporal heterogeneity of mouse and human microglia at single‐cell resolution publication-title: Nature – volume: 24 start-page: 1475 year: 2021 end-page: 1487 article-title: Neuroinflammatory astrocyte subtypes in the mouse brain publication-title: Nat Neurosci – volume: 14 start-page: 115 year: 2022 article-title: Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease publication-title: Alzheimers Res Ther – volume: 38 start-page: 6665 year: 2018 end-page: 6681 article-title: Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer's disease risk reduction and early intervention publication-title: J Neurosci Off J Soc Neurosci – volume: 71 start-page: 1183 year: 2014 end-page: 1191 article-title: Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease publication-title: JAMA Psychiatry – volume: 9 start-page: 168 year: 2021 article-title: TREM2 modulates differential deposition of modified and non‐modified Aβ species in extracellular plaques and intraneuronal deposits publication-title: Acta Neuropathol Commun – volume: 14 year: 2017 article-title: APOE‐related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts publication-title: PLoS Med – volume: 53 start-page: 1553 year: 2016 end-page: 1562 article-title: Interaction between midlife blood glucose and APOE genotype predicts later Alzheimer's disease pathology publication-title: J Alzheimers Dis JAD – volume: 53 start-page: 16 year: 2014 end-page: 23 article-title: ApoE gene and exceptional longevity: insights from three independent cohorts publication-title: Exp Gerontol – volume: 109 start-page: 205 year: 2021 end-page: 221 article-title: Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis publication-title: Neuron – volume: 9 start-page: 87 year: 2017 article-title: Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations publication-title: Alzheimers Res Ther – volume: 14 start-page: 412 year: 2017 end-page: 425 article-title: Targeting tumor necrosis factor alpha for Alzheimer's disease publication-title: Curr Alzheimer Res – volume: 26 start-page: 131 year: 2020 end-page: 142 article-title: Human and mouse single‐nucleus transcriptomics reveal TREM2‐dependent and TREM2‐independent cellular responses in Alzheimer's disease publication-title: Nat Med – volume: 10 start-page: 222 year: 2019 article-title: The genetic variability of APOE in different human populations and its implications for longevity publication-title: Genes – volume: 43 start-page: 1467 year: 1993 end-page: 1472 article-title: Association of apolipoprotein E allele epsilon 4 with late‐onset familial and sporadic Alzheimer's disease publication-title: Neurology – volume: 32 start-page: 18227 year: 2012 end-page: 18233 article-title: Initiative F the ADN. Apolipoprotein E, not fibrillar β‐amyloid, reduces cerebral glucose metabolism in normal aging publication-title: J Neurosci – volume: 541 start-page: 481 year: 2017 end-page: 487 article-title: Neurotoxic reactive astrocytes are induced by activated microglia publication-title: Nature – volume: 34 start-page: 22 year: 2013 end-page: 34 article-title: Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents publication-title: Neurobiol Aging – volume: 14 start-page: 388 year: 2015 end-page: 405 article-title: Neuroinflammation in Alzheimer's disease publication-title: Lancet Neurol – volume: 66 start-page: 616 year: 2014 end-page: 623 article-title: Apolipoprotein E isoforms and lipoprotein metabolism publication-title: IUBMB Life – volume: 12 start-page: 1 year: 2019 article-title: Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late‐onset Alzheimer's disease associated with obesity, metabolic syndrome, and type 2 diabetes publication-title: Alzheimers Res Ther – volume: 110 start-page: 1788 year: 2022 end-page: 1805 article-title: Astrocytes and oligodendrocytes undergo subtype‐specific transcriptional changes in Alzheimer's disease publication-title: Neuron – volume: 23 start-page: 500 year: 2020 end-page: 509 article-title: Astrocyte layers in the mammalian cerebral cortex revealed by a single‐cell in situ transcriptomic map publication-title: Nat Neurosci – volume: 13 start-page: 381 year: 2017 end-page: 387 article-title: Alzheimer's disease‐associated TREM2 variants exhibit either decreased or increased ligand‐dependent activation publication-title: Alzheimers Dement J Alzheimers Assoc – ident: e_1_2_12_66_1 doi: 10.1038/s41591‐019‐0695‐9 – ident: e_1_2_12_103_1 doi: 10.1186/s13024‐015‐0048‐1 – ident: e_1_2_12_117_1 doi: 10.1073/pnas.0900345106 – ident: e_1_2_12_90_1 doi: 10.1212/NXG.0000000000000571 – ident: e_1_2_12_27_1 doi: 10.3233/JAD‐160163 – ident: e_1_2_12_71_1 doi: 10.1038/s41593‐021‐00905‐6 – ident: e_1_2_12_114_1 doi: 10.1038/s41591‐019‐0611‐3 – ident: e_1_2_12_123_1 doi: 10.1186/s13195‐019‐0546‐4 – ident: e_1_2_12_69_1 doi: 10.1126/science.aal3222 – ident: e_1_2_12_19_1 doi: 10.1194/jlr.R800069‐JLR200 – ident: e_1_2_12_15_1 doi: 10.2217/17460875.3.5.505 – ident: e_1_2_12_85_1 doi: 10.1371/journal.pone.0219668 – ident: e_1_2_12_113_1 doi: 10.1016/j.nbd.2022.105630 – ident: e_1_2_12_13_1 doi: 10.1007/s00109‐016‐1427‐y – ident: e_1_2_12_72_1 doi: 10.1038/s41593‐020‐0602‐1 – ident: e_1_2_12_7_1 doi: 10.1016/j.biopsych.2017.05.014 – ident: e_1_2_12_18_1 doi: 10.1016/j.exger.2014.02.004 – ident: e_1_2_12_24_1 doi: 10.3390/nu7095341 – ident: e_1_2_12_45_1 doi: 10.1073/pnas.1525466113 – ident: e_1_2_12_11_1 doi: 10.1038/s41577‐018‐0051‐1 – ident: e_1_2_12_42_1 doi: 10.3389/fimmu.2020.00754 – ident: e_1_2_12_108_1 doi: 10.15252/emmm.201911227 – ident: e_1_2_12_68_1 doi: 10.1016/j.neuron.2017.04.043 – ident: e_1_2_12_55_1 doi: 10.1038/nn.3599 – ident: e_1_2_12_100_1 doi: 10.1177/0891988705281868 – ident: e_1_2_12_63_1 doi: 10.1038/s41593‐022‐01022‐8 – ident: e_1_2_12_41_1 doi: 10.1016/j.neurobiolaging.2012.09.012 – ident: e_1_2_12_21_1 doi: 10.1016/j.neuron.2017.09.003 – ident: e_1_2_12_97_1 doi: 10.1002/alz.051948 – ident: e_1_2_12_104_1 doi: 10.1016/j.jalz.2016.07.004 – ident: e_1_2_12_59_1 doi: 10.1016/j.neuron.2020.09.029 – ident: e_1_2_12_46_1 doi: 10.1038/s41467‐021‐22479‐4 – ident: e_1_2_12_77_1 doi: 10.1038/s41467‐021‐23762‐0 – ident: e_1_2_12_32_1 – ident: e_1_2_12_28_1 doi: 10.1186/s13195‐016‐0231‐9 – ident: e_1_2_12_58_1 doi: 10.1038/s41593‐018‐0296‐9 – ident: e_1_2_12_64_1 doi: 10.1016/j.neuron.2011.07.022 – ident: e_1_2_12_65_1 doi: 10.1038/s41586‐019‐0924‐x – ident: e_1_2_12_94_1 doi: 10.1001/jamaneurol.2018.0821 – ident: e_1_2_12_22_1 doi: 10.1523/JNEUROSCI.3266‐12.2012 – ident: e_1_2_12_109_1 doi: 10.1523/JNEUROSCI.1871‐19.2019 – ident: e_1_2_12_39_1 doi: 10.1093/brain/awy188 – ident: e_1_2_12_93_1 doi: 10.1038/s41593‐019‐0560‐7 – ident: e_1_2_12_48_1 doi: 10.1126/science.abf9277 – ident: e_1_2_12_3_1 doi: 10.1016/0197‐4580(95)00021‐6 – ident: e_1_2_12_84_1 doi: 10.1038/s41467‐021‐24220‐7 – ident: e_1_2_12_75_1 doi: 10.1038/s41586‐019‐1195‐2 – ident: e_1_2_12_57_1 doi: 10.1016/j.neuron.2019.12.007 – ident: e_1_2_12_34_1 doi: 10.1016/S1474‐4422(15)70016‐5 – ident: e_1_2_12_50_1 doi: 10.1016/j.chom.2009.06.007 – ident: e_1_2_12_49_1 doi: 10.1016/j.brainresrev.2006.11.002 – ident: e_1_2_12_78_1 doi: 10.1186/s13024‐020‐00394‐4 – ident: e_1_2_12_31_1 doi: 10.1016/j.bbi.2021.12.008 – ident: e_1_2_12_111_1 doi: 10.1186/s12974‐020‐01915‐0 – ident: e_1_2_12_56_1 doi: 10.1016/j.cell.2017.05.018 – ident: e_1_2_12_110_1 doi: 10.1186/s40478‐021‐01263‐x – ident: e_1_2_12_76_1 doi: 10.3892/etm.2021.9778 – ident: e_1_2_12_38_1 doi: 10.3389/fneur.2018.00625 – ident: e_1_2_12_61_1 doi: 10.1126/science.aay0793 – ident: e_1_2_12_102_1 doi: 10.1111/jgs.13627 – ident: e_1_2_12_5_1 doi: 10.1371/journal.pmed.1002270 – ident: e_1_2_12_96_1 doi: 10.2147/CLEP.S37929 – ident: e_1_2_12_101_1 doi: 10.3233/JAD‐150778 – ident: e_1_2_12_81_1 doi: 10.1001/jamapsychiatry.2014.1060 – ident: e_1_2_12_119_1 doi: 10.2174/1567205013666160930110551 – ident: e_1_2_12_14_1 doi: 10.1016/j.neuron.2020.10.008 – ident: e_1_2_12_120_1 doi: 10.1002/gps.4871 – ident: e_1_2_12_107_1 doi: 10.1016/j.neuron.2020.09.029 – ident: e_1_2_12_23_1 doi: 10.1523/JNEUROSCI.2262‐17.2018 – ident: e_1_2_12_8_1 doi: 10.1126/science.8346443 – ident: e_1_2_12_62_1 doi: 10.1016/j.neuron.2017.03.042 – ident: e_1_2_12_6_1 doi: 10.1017/s0317167100013949 – ident: e_1_2_12_112_1 doi: 10.1007/s00401‐020‐02193‐z – ident: e_1_2_12_115_1 doi: 10.1038/s41467‐019‐14279‐8 – ident: e_1_2_12_86_1 doi: 10.1097/WAD.0000000000000462 – ident: e_1_2_12_116_1 doi: 10.1001/jamaneurol.2015.1721 – ident: e_1_2_12_44_1 doi: 10.1038/s41586‐021‐03960‐y – ident: e_1_2_12_122_1 doi: 10.1124/pr.112.005850 – ident: e_1_2_12_95_1 doi: 10.1212/WNL.0000000000010629 – ident: e_1_2_12_36_1 doi: 10.1007/s12035‐014‐8657‐1 – ident: e_1_2_12_47_1 doi: 10.1126/science.abf7844 – ident: e_1_2_12_54_1 doi: 10.1016/j.neuron.2020.05.014 – ident: e_1_2_12_4_1 doi: 10.1016/j.jalz.2018.02.018 – ident: e_1_2_12_26_1 doi: 10.3233/JAD‐170767 – ident: e_1_2_12_92_1 doi: 10.1016/S1474‐4422(16)00067‐3 – ident: e_1_2_12_106_1 doi: 10.1084/jem.20200785 – ident: e_1_2_12_73_1 doi: 10.1016/j.immuni.2018.11.004 – ident: e_1_2_12_10_1 doi: 10.1212/wnl.43.8.1467 – ident: e_1_2_12_91_1 doi: 10.1038/s41582‐018‐0032‐9 – ident: e_1_2_12_88_1 doi: 10.3390/genes10030222 – ident: e_1_2_12_79_1 doi: 10.1186/s13195‐022‐01058‐9 – ident: e_1_2_12_70_1 doi: 10.1073/pnas.1525528113 – ident: e_1_2_12_43_1 doi: 10.3389/fimmu.2018.00586 – ident: e_1_2_12_30_1 doi: 10.1016/j.jns.2013.05.028 – ident: e_1_2_12_105_1 doi: 10.1038/s41593‐020‐0650‐6 – ident: e_1_2_12_118_1 doi: 10.1001/jama.2015.4668 – ident: e_1_2_12_87_1 doi: 10.3233/ADR‐200203 – ident: e_1_2_12_35_1 doi: 10.3389/fncel.2019.00063 – ident: e_1_2_12_25_1 doi: 10.1016/j.neurobiolaging.2012.03.002 – ident: e_1_2_12_29_1 doi: 10.3233/JAD‐210065 – ident: e_1_2_12_20_1 doi: 10.1016/j.nbd.2020.104755 – ident: e_1_2_12_33_1 doi: 10.1212/WNL.0000000000012512 – ident: e_1_2_12_2_1 doi: 10.1007/s00401‐014‐1375‐y – ident: e_1_2_12_40_1 doi: 10.1186/s13195‐020‐00628‐z – ident: e_1_2_12_60_1 doi: 10.1038/nn.4338 – ident: e_1_2_12_17_1 doi: 10.1371/journal.pmed.1002254 – ident: e_1_2_12_74_1 doi: 10.1016/j.neuron.2022.03.008 – ident: e_1_2_12_53_1 doi: 10.1038/nature21029 – ident: e_1_2_12_89_1 doi: 10.1002/alz.12205 – ident: e_1_2_12_98_1 doi: 10.1016/j.jalz.2015.12.007 – ident: e_1_2_12_67_1 doi: 10.1038/s41593‐022‐01061‐1 – ident: e_1_2_12_16_1 doi: 10.1002/iub.1314 – ident: e_1_2_12_51_1 doi: 10.1038/ncomms7176 – ident: e_1_2_12_52_1 doi: 10.15252/embj.201899430 – ident: e_1_2_12_80_1 doi: 10.1186/s13195‐017‐0313‐3 – ident: e_1_2_12_83_1 doi: 10.1093/brain/awaa325 – ident: e_1_2_12_99_1 doi: 10.1212/wnl.56.1.49 – ident: e_1_2_12_121_1 doi: 10.2147/jir.s4397 – ident: e_1_2_12_82_1 doi: 10.1016/j.nicl.2013.12.012 – ident: e_1_2_12_9_1 doi: 10.1073/pnas.90.5.1977 – ident: e_1_2_12_12_1 doi: 10.1093/jnen/nlab085 – ident: e_1_2_12_37_1 doi: 10.1016/j.jalz.2019.03.007 |
SSID | ssj0040815 |
Score | 2.4582667 |
SecondaryResourceType | review_article |
Snippet | INTRODUCTION
At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research... At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on... INTRODUCTION: At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research... INTRODUCTIONAt the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research... |
SourceID | swepub proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2677 |
SubjectTerms | Alzheimer Disease - pathology Alzheimer's disease amyloid beta APOE Apolipoproteins E - genetics astrocytes biomarkers dementia Humans Inflammation microglia Microglia - pathology neurodegeneration neuroglia neuroinflammation Neurosciences Neurovetenskaper tau TREM2 |
Title | APOE and immunity: Research highlights |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Falz.13020 https://www.ncbi.nlm.nih.gov/pubmed/36975090 https://www.proquest.com/docview/2825154866 https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-219590 https://gup.ub.gu.se/publication/327516 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NS8MwFA-iFy-i-DU_RhUduxTbtElaPQ23ISLqwY3hJaRJOgajG3Y96F_vS7pWhhO8hfalTV_ykt9L834PoSuNTc-SxI2ZiNwQYwk2Bz4PS6mIw9QXsbAHZJ_pwyB8HJHRBrqrYmFKfoh6w81Yhp2vjYGLJL_5IQ0V0y-TyhiDv74FoD4wwxuHr9U0HMJaRyxZKjHeFvUqWiEP39RVVxejXwizpg9dRa526envop0lZnQ6ZSfvoQ2d7aNW5_Wl54hMORMb4rH4vHWqY3SOISGeGrc7P0CDfu_t_sFdJj1wJSAXzyUpQJwImq-IwExj7KdBwEQMuELFWhkiWZ0GTBElFZGR8LDwBRiZ8BJBmYyCQ7SZzTJ9jJwkZZGS1KdM09CTMoZykCqfxqnnC081ULv6ei6XjOAmMcWUl1zGmIOiuFVUA13WovOSBmOd0EWlQg6D1Px5EJmeFTm3AbLgG1HaQEelbuvHBDQ2qAVqX5fKru8Y5uvuZNjhs48xzwuODREOyLXWyI2LOYdL44LnmgeYER9e1bad9neDeefp3RZO_i96irZNxvnytNgZ2lx8FPoccMkiadrx10RbL8Ner_sNXQLcyA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NS8MwFA9DD3oRxa_5WUWHl7I2bZJWvAw_mDqnB5XhJWRJOgajG9t60L_el3StDCd4C-1Lm77kJb-X5v0eQmcam54lXTdmInJDjCXYHPg8LKEiDhNfxMIekG3T5lv40CGdCroqYmFyfohyw81Yhp2vjYGbDen6D2uoGHyZXMYYHPblkILrYnidw5diHg5hsSOWLZUYd4t6Ba-Qh-tl1fnV6BfELPlD56GrXXvu1tHaDDQ6jbyXN1BFp5uo1nh5vnVEqpy-jfGYfl46xTk6x7AQD4zfPdlCb3e3r9dNd5b1wJUAXTyXJIBxImi-IgIzjbGfBAETMQALFWtlmGR1EjBFlFRERsLDwhdgZcLrCspkFGyjpXSY6l3kdBMWKUl9yjQNPSljKAeJ8mmceL7wVBVdFF_P5YwS3GSmGPCczBhzUBS3iqqi01J0lPNgLBI6KVTIYZSaXw8i1cNswm2ELDhHlFbRTq7b8jEBjQ1sgdrnubLLO4b6-qb_3uDDcY9PMo4NEw7I1RbI9bIRh0u9jE80DzAjPrzqwnba3w3mjdaHLez9X_QYrTRfn1q8dd9-3EerJv18fnTsAC1Nx5k-BJAy7R7ZsfgNT6bemA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bS8MwFA6iIL6I4m1eq6j4UtamTdLq03COeUH3oDJ8CVkuQxjdcOuD_npP0rUynOBbaE_a9OSc5Dtp8h2ETjW2PUt6fspE4scYS_A5iHmYoSKNTShS4TbIPtL2S3zXJd0FdFWehSn4IaoFN-sZbry2Dj5Spv5DGioGXzaVMYZ4fSkGu7PmjeNOOQzHMNcRR5ZKbLRFg5JWKMD1qursZPQLYVb0obPI1U09rTW0OsWMXqPo5HW0oLMNdN7oPN14IlPeuzviMfm89MptdJ4lIR7YsHu8iV5aN8_XbX-a9MCXgFwCnxiAOAk0XxGBmcY4NFHERAq4QqVaWSJZbSKmiJKKyEQEWIQCnEwEPUGZTKIttJgNM72DvJ5hiZI0pEzTOJAyhXJkVEhTE4QiUDV0UX49l1NGcJuYYsALLmPMQVHcKaqGTirRUUGDMU_ouFQhByO1fx5Epof5mLsDshAbUVpD24Vuq8dENLWoBWqfFcqu7ljm6-b7a4MPP_p8nHNsiXBA7nyOXD8fcbjUz_lY8wgzEsKrLlyn_d1g3nh4c4Xd_4seoeVOs8Ufbh_v99CKTT5fbBzbR4uTj1wfAESZ9A6dKX4DNOXd0w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=APOE+and+immunity%3A+Research+highlights&rft.jtitle=Alzheimer%27s+%26+dementia&rft.au=Kloske%2C+Courtney+M.&rft.au=Barnum%2C+Christopher+J.&rft.au=Batista%2C+Andre+F.&rft.au=Bradshaw%2C+Elizabeth+M.&rft.date=2023-06-01&rft.issn=1552-5260&rft.eissn=1552-5279&rft.volume=19&rft.issue=6&rft.spage=2677&rft.epage=2696&rft_id=info:doi/10.1002%2Falz.13020&rft.externalDBID=10.1002%252Falz.13020&rft.externalDocID=ALZ13020 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5260&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5260&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5260&client=summon |